Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naltrexone versus placebo for chronic plaque psoriasis
IRCT20120215009014N301Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in plaque psoriasis and psoriasis comparing Routine treatment + naltrexone with Routine treatment + placebo (2 arms). Primary endpoints: Improvement of the clinical signs of psoriasis and Quality of life. Started Oct 2019; status: completed.
02
Drugs
naltrexone
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on IRCT20120215009014N301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N301.